DETECTION OF TOTAL AND ROTAVIRUS SPECIFIC ANTIBODY SECRETING CELLS IN HEALTHY ADULTS
Detección de células secretoras de anticuerpos totales y específicas de rotavirus en adultos sanos
##plugins.themes.bootstrap3.article.sidebar##
PDF (Español (España))
FLIP
HTML (Español (España))
##plugins.themes.bootstrap3.article.main##
Antibodies (Ab) play a critical role in the immune response against rotavirus (RV). Protector Ab, are produced by antibody secreting cells (ASC). The capacity to detect ASC becomes fundamental in process like antiviral response analysis and vaccination testing. Here, we analyzed the frequency and isotype of total and RV-specific ASC by ELISPOT (functional assay) and flow cytometry (FC) in healthy adults using CD38
and CD27 like ASC markers. In each million of peripherals blood mononuclear cells (PBMC), approximately 2,550 totals ASC were detected. IgA was the isotype preferentially expressed for circulating ASC followed by IgG and IgM with 63%, 29.4% and 7.6% of total ASC respectively. Paired analysis of immunomagnetic sorting, ELISPOT and FC shown that 85% and 90% of total ASC expressed CD38 and CD27 respectively. CD38 and CD27 ASC enrichment population were used to detect RV-specific ASC. None to 40 ASC per million of PBMC were detected by ELISPOT and FC and more interesting yet, a high correlation were found in the frequency of RV-specific ASC detected by both methods. This mixture assay can be used in the evaluation of new RV vaccines.
Downloads
##plugins.themes.bootstrap3.article.details##
Angel, J., M. A. Franco, and H. B. Greenberg. Rotavirus vaccines: recent developments and future considerations. Nat Rev Microbiol. 2007; 5:529-39.
Arce, E., D. G. Jackson, M. A. Gill, L. B. Bennett, J. Banchereau, and V. Pascual. 2001. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 167:2361-9.
Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-202.
Brown, K. A., J. A. Kriss, C. A. Moser, W. J. Wenner, and P. Offit. 2000. Circulating Rotavirus-Specific Antibody-Secreting Cells (ASCs) Predict the Presence of Rotavirus-Specific ASCs in the Human Small Intestinal Lamina Propria. J Infect Dis 182:1039-1043.
Butcher, E. C., M. Williams, K. Youngman, L. Rott, and M. Briskin. 1999. Lymphocyte trafficking and regional immunity. Adv Immunol 72:209-253.
Charpilienne, A., M. Nejmeddine, M. Berois, N. Parez, E. Neumann, E. Hewat, G. Trugnan, and J. Cohen. 2001. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells. J Biol Chem 276:29361-7.
Fagarasan, S., and T. Honjo. 2003. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 3:63-72.
Franco, M. A., J. Angel, and H. B. Greenberg. 2006. Immunity and correlates of protection for rotavirus vaccines. Vaccine 24:2718-31.
Franco, M. A., and H. B. Greenberg. 1995. Role of B cells and Cytotoxic T Lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 69:7800-7806.
Gonzalez, A. M., M. C. Jaimes, I. Cajiao, O. L. Rojas, J. Cohen, P. Pothier, E. Kohli, E. C. Butcher, H. B. Greenberg, J. Angel, and M. A. Franco. 2003. Rotavirus-specific B cells induced by recent infection in adults and children predominantly express the intestinal homing receptor alpha4beta7. Virology 305:93-105.
Greenberg, H. B., and M. K. Estes. 2009. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136:1939-51.
Jaimes, M. C., O. L. Rojas, E. J. Kunkel, N. H. Lazarus, D. Soler, E. C. Butcher, D. Bass, J. Angel, M. A. Franco, and H. B. Greenberg. 2004. Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children. J Virol 78:10967-76.
Jego, G., N. Robillard, D. Puthier, M. Amiot, F. Accard, D. Pineau, J. L. Harousseau, R. Bataille, and C. Pellat-Deceunynck. 1999. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood 94:701-12.
Kantele, A. 1990. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 8:321-326.
Kantele, J. M., A. Kantele, and H. Arvilommi. 1996. Circulating immunoglobulin-secreting cells are heterogeneous in their expression of maturation markers and homing receptors. Clin Exp Immunol 104:525-30.
McNeal, M. M., K. S. Barone, M. N. Rae, and R. L. Ward. 1995. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 214:387-97.
Medina, F., C. Segundo, A. Campos-Caro, I. Gonzalez-Garcia, and J. A. Brieva. 2002. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99:2154-61.
Parashar, U. D., C. J. Gibson, J. S. Bresse, and R. I. Glass. 2006. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304-6.
Parashar, U. D., E. G. Hummelman, J. S. Bresee, M. A. Miller, and R. I. Glass. 2003. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565-72.
Parez, N., A. Garbarg-Chenon, C. Fourgeux, F. Le Deist, A. Servant-Delmas, A. Charpilienne, J. Cohen, and I. Schwartz-Cornil. 2004. The VP6 Protein of Rotavirus Interacts with a Large Fraction of Human Naive B Cells via Surface Immunoglobulins. J Virol 78:12489 - 12496.
Rojas, O. L., C. F. Narvaez, H. B. Greenberg, J. Angel, and M. A. Franco. 2008. Characterization of rotavirus specific B cells and their relation with serological memory. Virology 380:234-42.
Ruiz-Palacios, G. M., I. Perez-Schael, F. R. Velazquez, H. Abate, T. Breuer, S. C. Clemens, B. Cheuvart, F. Espinoza, P. Gillard, B. L. Innis, Y. Cervantes, A. C. Linhares, P. Lopez, M. Macias-Parra, E. Ortega-Barria, V. Richardson, D. M. Rivera-Medina, L. Rivera, B. Salinas, N. Pavia-Ruz, J. Salmeron, R. Ruttimann, J. C. Tinoco, P. Rubio, E. Nunez, M. L. Guerrero, J. P. Yarzabal, S. Damaso, N. Tornieporth, X. Saez-Llorens, R. F. Vergara, T. Vesikari, A. Bouckenooghe, R. Clemens, B. De Vos, and M. O’Ryan. 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11-22.
Vesikari, T., D. O. Matson, P. Dennehy, P. Van Damme, M. Santosham, Z. Rodriguez, M. J. Dallas, J. F. Heyse, M. G. Goveia, S. B. Black, H. R. Shinefield, C. D. Christie, S. Ylitalo, R. F. Itzler, M. L. Coia, M. T. Onorato, B. A. Adeyi, G. S. Marshall, L. Gothefors, D. Campens, A. Karvonen, J. P. Watt, K. L. O’Brien, M. J. DiNubile, H. F. Clark, J. W. Boslego, P. A. Offit, and P. M. Heaton. 2006. Safety and efficacy of a pentavalent humanbovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23-33.
Youngman, K. R., M. A. Franco, N. A. Kuklin, L. S. Rott, E. C. Butcher, and H. B. Greenberg. 2002. Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response. J Immunol 168:2173-81.
